Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$24,811,599
+$1,136,608 QoQ
Shares Held
97,695
+0.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#657
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. JNJ ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
97,695 | $24,811,599 | |
| 2 | ABBV |
AbbVie Inc.
|
86,259 | $21,706,214 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
179,351 | $10,334,204 | |
| 4 | LLY |
ELI LILLY & Co
|
7,425 | $8,905,768 | |
| 5 | BIIB |
Biogen Inc.
|
38,127 | $8,237,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,399 | $8,009,829 | |
| 7 | MRK |
Merck & Co., Inc.
|
38,429 | $4,938,126 | |
| 8 | NVS |
Novartis AG
|
29,083 | $4,557,887 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,811,599 | 97,695 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $23,674,991 | 96,854 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $20,227,499 | 97,741 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $18,531,616 | 99,944 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $18,486,568 | 121,025 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $20,489,863 | 123,552 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $17,423,528 | 120,478 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $21,927,528 | 135,305 | Shares | Sole | 2024-11-01 | |
| 2024-03-31 | $17,050,509 | 107,785 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $27,482,164 | 175,336 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $28,355,222 | 182,056 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,379,706 | 183,541 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $27,863,885 | 179,767 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $32,200,998 | 182,287 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $29,859,920 | 182,786 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $31,847,601 | 179,413 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $31,538,255 | 177,951 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $30,506,913 | 178,330 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $28,355,039 | 175,573 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,678,955 | 168,016 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $26,635,218 | 162,064 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,721,730 | 150,729 | Shares | Sole | 2021-02-23 | |
| 2020-09-30 | $19,393,406 | 130,262 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $15,659,009 | 111,349 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,897,941 | 113,612 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||